Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same

Details for Australian Patent Application No. 2007275177 (hide)

Owner Abbott GmbH & Co. KG

Inventors Liepold, Bernd; Lander, Ute; Marsh, Kennan; Breitenbach, Jorg; Rosenberg, Jorg; Schmidt, Christoph

Agent Spruson & Ferguson

Pub. Number AU-B-2007275177

PCT Pub. Number WO2008/009689

Priority 60/832,074 19.07.06 US; 06015076.0 19.07.06 EP

Filing date 17 July 2007

Wipo publication date 24 January 2008

Acceptance publication date 21 June 2012

International Classifications

A61K 9/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/427 - not condensed and containing further heterocyclic rings

A61K 31/513 - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 47/14 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/22 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

Event Publications

12 February 2009 PCT application entered the National Phase

  PCT publication WO2008/009689 Priority application(s): WO2008/009689

21 June 2012 Application Accepted

  Published as AU-B-2007275177

18 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007275179-Pyrimidine derivatives and their use as pesticides

2007275169-Ambient temperature thermal energy and constant pressure cryogenic engine